GW Pharma (GWPH) PT Raised to $164 at H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Nebius shares sink on CoreWeave's bond yield spike and insider sales
- IonQ prices $2 billion equity offering at $40 per share
- Rocket Lab delays Neutron rocket debut to 2027
- Bloom Energy stock falls as inflation data pressures markets
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
GW Pharma (GWPH) Tops Q2 EPS by 61c, Revenues Beat
August 6, 2020 4:01 PM EDTGW Pharma (NASDAQ: GWPH) reported Q2 EPS of ($0.02), $0.61 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $121.3 million versus the consensus estimate of $120.31 million.
FINANCIAL RESULTS
Total revenue for the quarter ended June 30, 2020 was $121.3 million compared to $72.0 million for the quarter ended June 30, 2019Net... More


